We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Time for the National Legislation of Indoor Tanning to Protect Minors

Marie-France Demierre, MD, FRCPC
Arch Dermatol. 2003;139(4):520-524. doi:10.1001/archderm.139.4.520.
Text Size: A A A
Published online


IN THIS issue of the ARCHIVES, 2 studies offer quite different perspectives on indoor tanning. Carlin et al1 report on the combination of acitretin and commercial tanning beds as an effective and useful therapy for psoriasis in geographic areas without access to physician-directed phototherapy. At the University of Utah Health Sciences Center, 26 patients with psoriasis who attended dermatology clinics were retrospectively surveyed in regard to treatments with acitretin and tanning bed light. Of 26 patients with moderate to severe plaque-type psoriasis, 23 received a follow-up physical examination. Nineteen (83%) of 23 experienced either clearance or new clearance of their psoriasis. The authors also conducted a small prospective study in 17 patients with moderate to severe plaque-type psoriasis. Patients received 25 mg of acitretin per day and 5 to 7 tanning sessions per week for 12 weeks. Of 14 patients who completed the study, Psoriasis Area and Severity Index and National Psoriasis Foundation scores decreased on average 78.6% and 79%, respectively, from baseline. Adverse events were generally mild to moderate.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

19 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...